| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | $2.44M | $3.26M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$1.30M | -$199.69K | -$29.35M | -$64.15M | -$7.39M |
| EPS (basic) | -0.1500 | -0.0300 | -4.2600 | -9.3100 | -1.0700 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |